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Abstract
At present there are strong indications that Pseudomonas aeruginosa exhibits an epidemic population structure; clinical
isolates are indistinguishable from environmental isolates, and they do not exhibit a specific (disease) habitat selection.
However, some important issues, such as the worldwide emergence of highly transmissible P. aeruginosa clones among
cystic fibrosis (CF) patients and the spread and persistence of multidrug resistant (MDR) strains in hospital wards with high
antibiotic pressure, remain contentious. To further investigate the population structure of P. aeruginosa, eight parameters
were analyzed and combined for 328 unrelated isolates, collected over the last 125 years from 69 localities in 30 countries
on five continents, from diverse clinical (human and animal) and environmental habitats. The analysed parameters were: i) O
serotype, ii) Fluorescent Amplified-Fragment Length Polymorphism (FALFP) pattern, nucleotide sequences of outer
membrane protein genes, iii) oprI, iv) oprL, v) oprD, vi) pyoverdine receptor gene profile (fpvA type and fpvB prevalence), and
prevalence of vii) exoenzyme genes exoS and exoU and viii) group I pilin glycosyltransferase gene tfpO. These traits were
combined and analysed using biological data analysis software and visualized in the form of a minimum spanning tree
(MST). We revealed a network of relationships between all analyzed parameters and non-congruence between experiments.
At the same time we observed several conserved clones, characterized by an almost identical data set. These observations
confirm the nonclonal epidemic population structure of P. aeruginosa, a superficially clonal structure with frequent
recombinations, in which occasionally highly successful epidemic clones arise. One of these clones is the renown and
widespread MDR serotype O12 clone. On the other hand, we found no evidence for a widespread CF transmissible clone. All
but one of the 43 analysed CF strains belonged to a ubiquitous P. aeruginosa ‘‘core lineage’’ and typically exhibited the
exoS+/exoU2 genotype and group B oprL and oprD alleles. This is to our knowledge the first report of an MST analysis
conducted on a polyphasic data set.
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Introduction
In his 1882 paper, ‘‘Sur les colorations bleue et verte des linges a`
pansements’’, introduced by Louis Pasteur, Carle Gessard
describes the isolation of an organism causing a blue-green
coloration of wound dressings [1]. He describes this ‘accidental’
organism as colourless, globular, 1 to 1.5 thousandths of a
millimetre in length, aerobic and very motile. The bacterium was
named Bacillus (rod) pyocyaneus. Today we refer to this organism as
Pseudomonas aeruginosa. This species is ubiquitous in the biosphere,
has wide metabolic versatility and high intrinsic and acquired
resistance to antimicrobials. It can be found in a wide variety of
ecological environments ranging from fresh and salt water to the
rhizosphere in which they colonize the endemic fauna (e.g.
nematodes), flora and fungi (e.g. Pythium spp.) [2]. The
opportunistic bacterium P. aeruginosa occasionally migrates from
its natural environment and causes disease in animals (wild,
domestic and livestock) and humans. In the latter it has emerged,
partly due to its intrinsic antibiotic resistance, as a major pathogen
in the airways of cystic fibrosis (CF) patients, causing often-fatal
chronic respiratory infections, and as one of the most clinically
significant opportunist nosocomial agents. Immunosuppressed
patients such as those with severe burns, cancer or AIDS are
particularly at risk.
Numerous research groups have demonstrated that P.
aeruginosa clinical isolates are genotypically, chemotaxonomi-
cally, and functionally indistinguishable from environmental
isolates. Ro¨mling et al. observed that the most frequently
identified clone in CF patients was also detected at a relatively
high frequency in aquatic environments [3] and Rahme et al.
demonstrated the infectivity of a P. aeruginosa strain in both plant
and animal models [4]. Similarly, P. aeruginosa strains isolated
from a gasoline-contaminated aquifer were indistinguishable
from clinical isolates [5] and both oil-contaminated soil isolates
and clinical isolates showed pathogenic and biodegradative
properties [6].
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Population structure
Using multilocus enzyme electrophoresis, Maynard Smith and
colleagues demonstrated that bacterial population structures could
range from panmictic or fully sexual, with random association
between alleles, to clonal, with nonrandom association of alleles,
the latter resulting in the frequent recovery of relatively few of the
many possible multilocus genotypes [7]. An intermediate type of
population structure that is predominantly sexual, but harbours
some epidemic clones, which show significant association between
loci, was called ‘epidemic’.
The population structure of P. aeruginosa has been the subject of
numerous investigations, we present an overview. Both Denamur
et al. in 1993, and Picard et al. in 1994, suggested a panmictic
population structure for the species but highlighted the need for
caution in inferring the population structure from any single class
of genetic marker [8,9]. In 2000, comparative sequencing of 19
environmental and clinical isolates revealed a net-like population
with a high frequency of recombination between isolates [10].
Using randomly amplified polymorphic DNA typing, Ruimy et al.
demonstrated that bacteremia and pneumonia were not caused by
specific P. aeruginosa clones [11]. In 2001 Lomholt and colleagues
suggested an epidemic population structure for a P. aeruginosa
population isolated mainly from patients with keratitis and their
environment [12]. They found evidence for an epidemic clone that
is pathogenic to the eye and is characterized by a distinct
combination of virulence factors. In 2002, we combined the data
obtained by 4 different typing methods, performed on a batch of
73 unrelated clinical and environmental P. aeruginosa isolates,
collected across the world and observed a clear mosaicism in the
results and a non-congruence between experiments, features of a
panmictic population structure [13]. But, in this network we also
observed some clonal complexes characterized by an almost
identical data set. There was no obvious correlation between these
dominant clones and habitat or, with the exception of some recent
clones, their geographical origin. Therefore, we suggested an
epidemic population structure for P. aeruginosa. Using multi locus
sequence typing (MLST), Curran et al. confirmed in 2004 that P.
aeruginosa exhibits a nonclonal epidemic population structure [14].
The P. aeruginosa population in the River Woluwe in Brussels was
found to be almost as diverse as the global population, harbouring
members of nearly all successful clonal complexes [15].
Several groups found that P. aeruginosa possessed a highly
conserved genome, which encoded genes important for survival in
numerous environments including humans and evolved through
the acquisition, loss, and reorganisation of genome islands and
genome islets [16–20]. Horizontal gene transfer (HGT) might play
a more important role than point mutation in the adaptation of P.
aeruginosa to different habitats. Despite not believed to be naturally
competent, P. aeruginosa displays a high level of interstrain genomic
plasticity and contains a high number of unfixed genes. Shen et al.
put forward the idea of a population-based supra-genome that is
substantially larger than the genome size of any of the component
strains [21]. No two strains would be identical in terms of their
genetic content and HGT continuously creates new strains with
unique genetic characteristics.
Environmentally endemic bacteriophages are probably respon-
sible for a fair amount of HGT, as they were shown to be
formidable transducers of naturally occurring microbial commu-
nities of P. aeruginosa [22].
In 2006 Lee and colleagues tested the pathogenicity of diverse P.
aeruginosa strains in a Caenorhabditis elegans pathogenicity model and
showed that genes required for pathogenicity in one strain of P.
aeruginosa were neither required for, nor predictive of virulence in
other strains [23]. They concluded that virulence in P. aeruginosa is
both multifactorial and combinatorial, the result of a pool of
pathogenicity-related genes that interact in various combinations
in different backgrounds.
In 2007 Wiehlmann and colleagues analysed 240 P. aeruginosa
strains with a DNA array tube assay and reported the segregation
of strains from diverse habitats and geographic origin into two
large nonoverlapping clusters and 45 isolated clonal complexes
composed of a few or even single strains [24]. The majority of
strains belonged to a few dominant clones widespread in disease
and environmental habitats.
In conclusion, there appears to be a consensus that the P.
aeruginosa population structure is nonclonal epidemic, that clinical
isolates are indistinguishable from environmental isolates, and that
there are no specific clones with a specific (disease) habitat
selection. The P. aeruginosa genome consists of a highly conserved
core spiked with mobile islands and elements, which are
exchanged between strains through intensive and basically
phage-mediated HGT, thus creating the striking diversity of this
ubiquitous opportunistic pathogen.
Despite the above-mentioned studies, some important conten-
tious issues remain. First, since the 1980s several studies have
reported the emergence, spread and persistence of multidrug
resistant (MDR) clones in hospitals, mainly in intensive care wards
with high antibiotic pressure. Two serotypes, O11 and O12, are
highly associated with these epidemic strains [25–47]. Typing of
these strains supported a heterogeneous population in serotype
O11 but those of serotype O12 often appeared to lack significant
diversity.
Second, since the second half of the 1990s, an increasing
number of P. aeruginosa ‘transmissible’ CF clones have been
reported worldwide [48–60], suggestive of an emergence of
specific clones that have adapted to the CF airway environment
and are spreading within CF populations.
This study
To provide a reference evolutionary framework and to position
these emergent P. aeruginosa clones in the global population
structure, we decided to expand our earlier study [13] both in
terms of number and range of isolates and of characters
investigated. Our starting material consisted of a collection of
328 unrelated isolates, collected over the last 125 years from 69
localities in 30 countries on 5 continents, including isolates from
diverse clinical (human and animal) and environmental habitats
(Table 1).
Since different (genetic) markers have been shown to measure
different evolutionary forces, confirming the importance of a
polyphasic approach to population analysis [8,9,19,61,62], we
decided to analyse and combine data from eight parameters that
are equally dispersed over the P. aeruginosa genome (Table 2). The
parameters investigated were i) O-serotype, ii) total genome profile
by fluorescent amplified-fragment length polymorphism (FAFLP)
analysis, nucleotide sequence of the outer membrane protein genes
iii) oprI, iv) oprL, and v) oprD, vi) pyoverdine receptor gene profile
(fpvA type and fpvB prevalence), and the prevalence of vii)
exoenzyme genes exoS and exoU and viii) group I pilin
glycosyltransferase gene tfpO.
Serotyping only allows for a crude discrimination between
different P. aeruginosa isolates, but because it has been performed all
over the world for more than 80 years [63] it forms a bridge
between old and new epidemiological studies.
FAFLP is a highly discriminatory and reproducible genotyping
method based on the selective amplification of a subset of DNA
fragments generated by restriction enzyme digestion [64–66].
P. aeruginosa Population
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Table 1. Origin of the P. aeruginosa strains (summary).
Locality Country CF Clinical non CF Animal Environment Hospital environment Unknown
Buenos Aires Argentina 1
Hobart Australia 2 15 2 1
Melbourne Australia 1 1
Antwerp Belgium 2
Brussels Belgium 9 13 13 6
De Haan Holiday Camp Belgium 4
Geel Belgium 1
Ghent Belgium 5 4 1
Leuven Belgium 3 2
North sea Belgium 1
Cotonu Benin 1
Sofia Bulgaria 5 1
Vancouver Canada 2
Chengdu China 1
Cali Colombia 3 1
Prague Czech Republic 1 2 1
Lwiro Democratic Republic of Congo 2
Nantes France 1
Paris France 14 1
Tbilisi Georgian Republic 2
Hanover Germany 7 2
Mulheim Germany 2
Ruhr River Germany 1
Aachen Germany 3
Athens Greece 5
Budapest Hungary 3 2
IDEXX Laboratories India 11
Pordenone Italy 1
Lake Tamako Japan 2
Otshuchi Bay Japan 1
Pacific Ocean Japan 10
Sagami Bay Japan 3
Zenpukujii Pond Japan 1
Arakawa River Japan 2
Suruga Bay Japan 2
Loltun Mexico 1
Karachi Pakistan 2
Panama City Panama 10
Lisbon Portugal 4 1
Veterinary Portugal 35
Canas Puerto Rico 1
Unknown Puerto Rico 1
Bucarest Roumania 7 1 1
Beverwijk The Netherlands 4
Holiday Camps The Netherlands 1
Rotterdam The Netherlands 1
Tacloban City The Philippines 1
Unknown The Philippines 1
Mediterranean sea Tunisia 1
Tunis Tunisia 3
P. aeruginosa Population
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Although it is generally assumed that the best means of indexing
natural variation in a population structure is to sequence
housekeeping genes [67] we previously showed that the DNA
sequence of the oprI, oprL and oprD genes generated equally
discriminative data [13]. The oprI and oprL genes, which code for
outer membrane lipoproteins [68–71], showed sequence diversity
comparable to that of housekeeping genes [13] and have been
included in SNP schemes [19].
The P. aeruginosa oprD gene codes for a specialized pore protein,
OprD, which allows selective permeation of basic amino acids and
their structural analogs like the carbapenem antibiotics imipenem
and meropenem [72,73]. It exhibits important sequence variability
with multiple non-silent mutations and a microscale mosaic
structure resulting from multiple recombinational events [74]. The
oprD sequence data have proven to be an extremely interesting
genetic marker, for the following reasons: (i) resistance to
carbapenems is often achieved by defective oprD mutations
(DOMs), (ii) the mosaic structure of the oprD gene exposes
evidence of recombination events between P. aeruginosa strains,
(iii) the virtually unlimited number of oprD alleles provides high
discriminatory power, (iv) despite this extremely high sequence
variability, members of narrow clonal complexes often show
identical oprD sequences, thus illustrating the stability of these
complexes [13].
Pyoverdines are high-affinity fluorescent peptidic siderophores
secreted by P. aeruginosa in order to scavenge Fe(III) in the
extracellular environment and shuttle it into the cell [75]. Uptake
of the pyoverdine-Fe(III) complex is mediated by FpvA, a specific
outer membrane receptor protein. Three P. aeruginosa siderovars
can be distinguished, each producing a different pyoverdine
(type I, II and III) and a matching cognate FpvA receptor [76–78].
The type II pyoverdine receptors are more diverse and it has been
suggested that they are under positive selection [79–80]. Two
distinct type II pyoverdine receptor gene clusters were observed:
IIa and IIb [81]. In 2004, an additional pyoverdine receptor,
FpvB, was discovered [82]. It was found to confer, in pyoverdine
type II and III producing P. aeruginosa strains, the capacity to utilize
type I pyoverdine as a source of iron. The majority of P. aeruginosa
strains were shown to possess the fpvB gene.
ExoS and ExoU are effector molecules (exoenzymes) that can be
injected directly into the host cell by the type III secretion system.
There are indications that ExoS is the major cytotoxin required for
colonization and dissemination during infection, while secretion of
ExoU has been associated with increased virulence [83,84].
Locality Country CF Clinical non CF Animal Environment Hospital environment Unknown
Istanbul Turkey 6
Birmingham UK 1
Cambridge UK 1
Colindale UK 1
Elstree UK 3
IDEXX Laboratories UK 10
Liverpool UK 1
London UK 9
Manchester UK 1
NIMR UK 2
Roehampton UK 1
Surrey UK 1
Ann Arbor US 3
Boston US 5
California US 2
Detroit US 1
Jekyll Island US 5 5
Kentucky US 2
San Antonio US 9
69 localities 30 countries (5 continents) 43 142 63 55 13 12
doi:10.1371/journal.pone.0007740.t001
Table 1.Cont.
Table 2. Genomic localisation of the parameters investigated
in this study.
Gene Genomic localization (Mb)*
oprD ,1.04
oprL ,1.06
fpvA ,2.66
oprI ,3.21
Serotype (wbpM-himD) ,3.53
exoS ,4.30
exoU ,4.58
fpvB ,4.66
tfpO (pilO) ,5.07
*Localisation in the genome of reference strain PAO1 (reference strain UCBPP-
PA14 for exoU) according to the Pseudomonas aeruginosa Genome Database
(http://www.pseudomonas.com).
doi:10.1371/journal.pone.0007740.t002
P. aeruginosa Population
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The pilin glycosyltransferase TfpO (also called PilO) is an inner
membrane protein that captures O antigen subunits and attaches
them to a serine residue at the carboxy terminus of the group I
pilins [85]. The group I pilin-containing strains can be divided into
subgroups: TfpOa (pilin group Ia) strains and TfpOb (pilin group
Ib) strains. Analysis of pilin allele distribution among isolates from
various sources revealed a striking bias in the prevalence of isolates
with group I pilin genes from CF compared with non-CF human
sources, suggesting that this particular pilin type may confer a
colonization or persistence advantage in the CF host [86].
The above-described traits were combined and analysed using
biological data analysis software. The results were visualised using
a minimum spanning tree (MST).
Finally, the minimum inhibitory concentrations (MIC) of 21
antimicrobials were determined for the 328 isolates.
Results and Discussion
Serotype
Only 215 (65%) out of the 328 strains could be serotyped
(Table 3). This surprisingly low percentage is partially due to the
nonagglutinability of 33 out of 43 CF isolates. Additionally, we
suspect that the commercially available monoclonal antibody
suspensions are not as potent as some of the homemade antisera
that were used in past studies. Eleven strains, including 5 CF
isolates, were polyagglutinable. Nonagglutinable strains have lost
most or all of their lipopolysaccharide (LPS) and polyagglutinable
strains have lost part or all of their O-repeating saccharide units,
which determine serotype specificity, due to a defective LPS side
chain synthesis [87,88]. Cross-reactions in agglutination are due to
core LPS epitopes, which are conserved in all the serotypes. Loss
of O serotype reaction was described as one of the distinctive
features for P. aeruginosa strains isolated from CF patients with
chronic bronchopulmonary infection [89]. Already in 1975 Zierdt
and Williams reported that isolates from CF patients were
frequently polyagglutinable [90]. The predominant serotypes in
our collection were O11 (20.1%), O6 (14.2%), O1 (11.9%) and
O12 (7.9%) (Table 3). This is in congruence with the findings of
Bert and Lambert-Zechowsky, who determined the O-serotypes of
2952 P. aeruginosa isolates and found serotypes O11, O6 and O1
to be predominant [91]. The incidence of O12, however, was low.
The higher prevalence of serotype O12 in our collection is due to
an overrepresentation of MDR strains. As could be expected, most
MDR clinical isolates exhibited serotypes O11 and O12 (Figure 1,
Figure 2, Figure 3, Figure 4, and Table 3). Finally, we would like
to stress that the occasional clustering of isolates with different
serotypes is not necessarily the result of recombinational events. It
was demonstrated that anti-pseudomonal drugs [92] and bacte-
riophages [93] were able to induce serotype conversion in P.
aeruginosa.
FAFLP
The FAFLP patterns of the P. aeruginosa strains were normalised
and clustered using the Unweighted Pair Group Method with
Arithmetic mean (UPGMA). By applying the criteria for
differentiation of P. aeruginosa by FAFLP [94], which were based
on the criteria for pulsed-field gel electrophoresis [95], 44 clusters
of related isolates (with $80% homology) were identified and
numbered (Figure 1, Figure 2, Figure 3, Figure 4, and Figure S1).
The close genetic relationship between some isolates, illustrated by
an almost identical data set (Figure 1, Figure 2, Figure 3, Figure 4),
also resulted in very similar FAFLP patterns (Figure S1). This
shows that FAFLP can be used, in clinical settings for example, to
recognize epidemic P. aeruginosa clones during short time spans. In
contrast, the relationship between the different clonal complexes,
and sometimes even between distinct clones within a complex, was
not always supported by FAFLP (Figure 1, Figure 2, Figure 3,
Figure 4). This is illustrated by a congruence of only 54% (lineair
correlation) between the similarity matrix of FAFLP and the
matrix derived from a combination of all the methods (Figure 5).
FAFLP is useful to discriminate between isolates, when investi-
gating local epidemics, but on its own it is not capable to identify
clonal complexes and elucidate the population structure of P.
aeruginosa.
ExoS and exoU
Seventy-three percent of all isolates harboured the exoS gene
and 23% the exoU gene (Table 3). With the exception of three
strains, the carriage of exoU and exoS was mutually exclusive and in
10 isolates neither of the genes could be amplified by PCR
(Table 3). Interestingly, 42 of the 43 CF isolates exhibited the
exoS+/exoU- genotype (Table 3). This could mean that the presence
of exoS, which is indicative of an invasive phenotype [96], and/or
the absence of exoU, which has been associated with virulence [83–
84] and severity of disease [97], is mandatory for successful
colonisation of the CF lung. These results are in congruence with
earlier reports. Feltman and colleagues observed that 72% of P.
aeruginosa isolates contained the exoS gene and 28% the exoU gene
[98]. The presence of the exoS and exoU genes appeared to be
mutually exclusive and they also observed that CF isolates
harboured more frequently the exoS gene and less frequently the
exoU gene than did isolates from other sites of infection, including
the respiratory tract of patients without CF. Wareham and Curtis
also observed an association of the exoS+/exoU2 genotype with
chronic infection in CF patients, whilst the exoS2/exoU+ genotype
was associated with strains isolated from blood [99]. The mutual
exclusion of exoS or exoU indicates that selective pressures
contributed to the evolution of these genomes in different
environmental niches [17]. Because the type III secretion system
secretes both ExoS and ExoU, the adaptation to either one of
these exoenzymes almost certainly involved interaction with
different target eukaryotic organisms. Accordingly, Ferguson et
al. suggested that in the transition of P. aeruginosa from the soil to
certain clinical settings, the loss of ExoS expression is favoured
[100]. In clinical settings the inactivation of host cell function
[101] and the antiphagocytic properties [102] of ExoS should aid
in the infectious process, but its limited cytotoxicity, combined
with its inefficient targeting of cells of lymphoid origin, may favour
the production of more cytotoxic factors, such as ExoU and
exotoxin A [103], at certain sites of P. aeruginosa infection.
Kulasekara et al. suggested that the evolutionary history of the exoU
locus more than likely involved transposition of the ExoU
determinant onto a transmissible plasmid, followed by transfer of
this plasmid into different P. aeruginosa strains [104]. This is in
accordance with our results and would explain the three strains that
harbour both exoS and exoU. The acquisition of novel genetic material,
such as the exoU genomic island, through HGT, may enhance
colonisation and survival in different host environments [17].
OprI, oprL, and oprD
The oprI, oprL, and oprD sequences of the 328 studied P.
aeruginosa strains were aligned and clustered using UPGMA. Allele
codes were arbitrarily assigned and consisted of a capital letter for
the allele group and a number, according to their position in the
alignment (Figure 6). The oprI and oprL genes showed moderate
sequence variability comparable to that of housekeeping genes, as
could be expected since both genes code for a structural outer
membrane lipoprotein (Table 4). The oprI, oprL and oprD sequences
P. aeruginosa Population
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of strains LMG 5031, Br680, CPHL 11451 and PA7 diverged
considerably (Figure 6). With the exception of one isolate, all
mutations in oprI and oprL were silent (http://www.pseudomonas.
com/related_links.jsp#alleles). All CF isolates but one possessed
the group B oprL allele (Figure 1, Figure 2, Figure 3, Figure 4, and
Table 3). Since non-silent mutations are extremely rare in oprL, the
conservation of distinct alleles within a clonal complex or clone is
likely the result of a genetic linkage or co-selection.
The oprD gene showed the expected high sequence variability
(Figure 6C and Table 4), typical for a gene that is under
strong selection for diversity (http://www.pseudomonas.com/
related_links.jsp#alleles). The oprD genes of strains US376 and
W15 Oct 31 could not be amplified by PCR. The oprD gene of
these strains is probably not present or exhibits an aberrant
nucleotide sequence (at least at the primer annealing sites). With
the exception of three isolates (Li004, 5BR2 and MC086), all CF
isolates exhibited a group B oprD allele (Figure 1, Figure 2,
Figure 3, Figure 4, and Table 3). Although genetic linkage or co-
selection between group B oprD alleles and parameters that have a
significant impact on selection in the CF lung are likely, the
important intergroup amino acid differences, especially in the
external loops of the OprD porin [74], could be indicative of a
more decisive role for OprD in the selection for strains in the CF
niche. The actual weight of OprD as a selection force in the CF
niche cannot be determined from our data and needs further
investigation. Twenty-one different defective oprD mutations
(DOMs), conferring resistance to carbapenem antibiotics, were
observed (Table 3 and Table 5). Seven (16.3%) of the 43 CF
isolates exhibited a DOM and as a consequence are expected to
express no OprD porin. This could mean that if OprD is truly a
selective force in the CF niche, it is likely that it will only be of
importance in the early stages of colonisation. Additionally, this
relatively high percentage of DOMs suggests that carbapenems
have an impact on P. aeruginosa in the CF lung. Finally, from the
Table 3. Differential prevalence (%) of strain characteristics.
Experiment Type/group CF Clinical non-CF Animal Environ-mental Total* O11 O12 clone pre 1980
Number of strains 43 142 63 55 303 61 20 49
Serotype O1 5 (11.6) 8 (5.6) 11 (17.5) 12 (21.8) 36 (11.9) 0 (0) 0 (0) 5 (10.2)
O6 4 (9.3) 15 (10.6) 15 (23.8) 9 (16.4) 43 (14.2) 0 (0) 0 (0) 11 (22.4)
O11 0 (0) 38 (26.8) 11 (17.5) 12 (21.8) 61 (20.1) 61 (100) 0 (0) 3 (6.1)
O12 0 (0) 23 (16.2) 0 (0) 1 (1.8) 24 (7.9) 0 (0) 20 (100) 0 (0)
NT 28 (65.1) 39 (27.5) 18 (28.6) 13 (23.6) 98 (32.3) 0 (0) 0 (0) 16 (32.7)
PA 5 (11.6) 3 (2.1) 0 (0) 1 (1.8) 9 (3.0) 0 (0) 0 (0) 2 (4.1)
other 1 (2.3) 16 (11.3) 8 (12.7) 7 (12.7) 32 (10.6) 0 (0) 0 (0) 12 (24.5)
exoS/U S 42 (97.7) 98 (69.0) 46 (73.0) 34 (61.8) 220 (72.6) 13 (21.3) 20 (100) 41 (83.7)
U 1 (2.3) 36 (25.4) 15 (23.8) 18 (32.7) 70 (23.1) 45 (73.8) 0 (0) 2 (4.1)
S+U 0 (0) 3 (2.1) 0 (0) 0 (0) 3 (1.0) 1 (1.6) 0 (0) 0 (0)
NA 0 (0) 5 (3.5) 2 (1.6) 3 (5.5) 10 (3.3) 2 (3.3) 0 (0) 6 (12.2)
oprD A 1 (2.3) 41 (28.9) 2 (1.6) 15 (27.3) 59 (19.5) 13 (21.3) 20 (100) 10 (20.4)
B 40 (93.0) 47 (33.1) 29 (46.0) 25 (45.5) 141 (46.5) 3 (4.9) 0 (0) 27 (55.1)
C 2 (4.7) 53 (37.3) 32 (50.8) 14 (25.5) 101 (33.3) 44 (72.1) 0 (0) 12 (24.5)
NA 0 (0) 1 (0.7) 0 (0) 1 (1.8) 2 (0.7) 1 (1.6) 0 (0) 0 (0)
DOM 7 (16.3) 15 (10.6) 0 (0) 0 (0) 22 (7.3) 9 (14.8) 4 (20.0) 0 (0)
oprL A 1 (2.3) 16 (11.3) 10 (15.9) 12 (21.8) 39 (12.9) 15 (24.6) 0 (0) 4 (8.2)
B 42 (97.7) 119 (83.8) 46 (73.0) 37 (67.3) 244 (80.5) 43 (70.5) 20 (100) 40 (81.6)
other 0 (0) 7 (4.9) 7 (11.1) 6 (10.9) 20 (6.6) 3 (4.9) 0 (0) 5 (10.2)
oprI A 8 (18.6) 23 (16.2) 18 (28.6) 2 (3.6) 51 (16.8) 3 (4.9) 0 (0) 13 (26.3)
B 35 (81.4) 113 (79.6) 45 (71.4) 52 (94.5) 245 (80.9) 57 (93.4) 20 (100) 33 (67.3)
other 0 (0) 6 (4.2) 0 (0) 1 (1.8) 7 (2.3) 1 (1.6) 0 (0) 3 (6.1)
fpvA I 11 (25.6) 38 (26.8) 26 (41.3) 29 (52.7) 104 (34.3) 18 (29.5) 0 (0) 18 (36.7)
IIa 5 (11.6) 23 (16.2) 12 (19.0) 8 (14.5) 48 (15.8) 10 (16.4) 0 (0) 8 (16.3)
IIb 20 (46.5) 43 (30.3) 18 (28.6) 13 (23.6) 94 (31.0) 22 (36.1) 0 (0) 5 (10.2)
III 7 (16.3) 38 (26.8) 7 (11.1) 5 (9.1) 57 (18.8) 11 (18.0) 20 (100) 8 (16.3)
fpvB POS 43 (100) 131 (92.3) 57 (90.5) 48 (87.3) 279 (92.1) 57 (93.4) 20 (100) 41 (83.7)
NA 0 (0) 11 (7.7) 6 (9.5) 7 (12.7) 24 (7.9) 4 (6.6) 0 (0) 8 (16.3)
tfpO a 0 (0) 0 (0) 0 (0) 2 (3.6) 2 (0.7) 0 (0) 0 (0) 1 (2.0)
b 24 (55.8) 70 (49.3) 26 (41.3) 24 (43.6) 144 (47.5) 10 (16.4) 19 (95.0) 27 (55.1)
NA 19 (44.2) 72 (50.7) 37 (58.7) 29 (52.7) 157 (51.8) 51 (83.6) 1 (5.0) 21 (42.9)
CF, cystic fibrosis; DOM, defective oprD mutation; NA, no amplification; NT, not typable; PA, polyagglutinable; POS, positive.
*Strains of unknown origin (n = 12) and strains isolated from the hospital environment (n = 13) were not considered.
doi:10.1371/journal.pone.0007740.t003
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Figure 1. Overview of the characteristics and test results of P. aeruginosa strains 1-82/328. ABR: antibiotic resistance; ATCC: American Type
Culture Collection; BWC: burn wound centre; CC: clonal complex; CF: cystic fibrosis; COPD: chronic obstructive pulmonary disease; CPHL: Central
Public Health Laboratory, London; DOM: defective oprD mutation; ESP: Ecole de Sante´ Publique, Brussels; FAFLP: fluorescent amplified fragment
length polymorphism; HPA: Health protection Agency, Colindale; HSV: high sequence variability; IDEXX: laboratory for veterinary, food and water
testing; ICU: intensive care unit; IG: insufficient growth; LMG: Laboratorium voor Microbiologie Gent, public bacteria collection; NA: no amplification;
NIMR: National Institute for Medical Research, London; NT: not typable; POS: positive; TRM: reaction terminated. * ABR: antibiotic resistance,
expressed as the number of antibiotic classes to which resistance was observed. ** Detected using degenerate primers.
doi:10.1371/journal.pone.0007740.g001
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Figure 2. Overview of the characteristics and test results of P. aeruginosa strains 83-164/328.
doi:10.1371/journal.pone.0007740.g002
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Figure 3. Overview of the characteristics and test results of P. aeruginosa strains 165-246/328.
doi:10.1371/journal.pone.0007740.g003
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Figure 4. Overview of the characteristics and test results of P. aeruginosa strains 247-328/328.
doi:10.1371/journal.pone.0007740.g004
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congruence chart (Figure 5) we learn that the similarity matrix
obtained from the oprD data alone is almost identical to that
obtained from oprD, oprL and oprI combined, indicating that oprL
and oprI add little or nothing to the discriminatory power of oprD.
Pyoverdine receptors
No significant correlation could be established between the fpvA
pyoverdine receptor gene type and habitat (Table 3). De Vos et al.
reported a prevalence of pyoverdine type II isolates in CF patients
and suggested that there might be a correlation between fpvA type
and the (clinical) origin of the P. aeruginosa isolates [105]. We did
observe a higher prevalence of pyoverdine type II, and more
specifically type IIb (46.5%), in the CF isolates as compared to the
total collection (31.0%) (Table 3), but it seems unlikely that the
pyoverdine receptor is in itself a selective force in the CF niche.
The relatively unordered distribution of the different pyoverdine
receptor types over the different clonal complexes is suggestive for
multiple recombinatorial events involving pyoverdine receptors
(Figure 1, Figure 2, Figure 3, Figure 4) and a complex evolutionary
history. Tu¨mmler and Cornelis reviewed the evolution of the
pyoverdine receptor in P. aeruginosa and claimed that the
pyoverdine region is the most divergent locus of the core genome
because it is subject to speciation and coevolution, encodes a trait
of altruistic cooperation (the production of siderophores), and
encodes a receptor that is both a major fitness allele and a major
deleterious allele [79]. Indeed, the mosaic dispersal of fpvA types
among the different clonal complexes (Figure 1, Figure 2, Figure 3,
Figure 4) is possibly the result of the selection pressure caused by
bacteriocins, which use the pyoverdine receptors to enter the
bacteria. Pyocin S3 was shown to use the type II FpvA receptor,
while pyocin S2 was found to kill strains harbouring the type I
FpvA receptor [106–107].
As expected, the fpvB gene was present in the majority (93.4%)
of P. aeruginosa isolates, including all 43 CF isolates.
TfpO
The tfpO gene, indicative for group I pilins, was detected in
48.2% of isolates (Table 3). The tfpOa allele was very rare; it was
only detected in four isolates (Table 3). The tfpO gene was present
in 55.8% of CF isolates, which is only slightly higher than the
average (48.2%). Thus, in contrast to Kus et al. [86] who detected
the tfpO gene in 69.7% of CF isolates, we did not find a strong
association of tfpO with CF. The tfpO data were found to have only
very limited value and discriminatory power and were therefore
not included in the combined analysis.
Population structure
MSTs have long been used in the context of mathematical
topology. When a set of distances is given between entries (strains
in this case), a minimum spanning tree connects all entries in such
a way that the summed distance of all branches of the tree is the
shortest possible [108]. In a biological context, this principle
adheres to the idea that evolution should be explained in as few
events as possible. MST suffers from a serious degree of
degeneracy as it generates a large number of solutions, many of
which have no biological relevance. Hence, priority rules are
applied in order to find or assign the biologically most relevant
solution amongst the many solutions. MST analysis was originally
developed to link MLVA-derived sequence types (STs) [109], but
technically it can be used for any data type, as long as a true
distance matrix can be calculated. The MST principle, however,
requires that all samples are present in the data set to construct the
tree. Internal branches are normally also based upon existing
samples. This means that, when an MST is calculated for
evolutionary studies, there are two important conditions that have
to be met: (1) the study must focus on a short time-frame, assuming
that all forms or states are still present, and (2) the sampled data set
must be sufficiently complete to enable the method to construct a
valid tree, i.e. representing the full biodiversity of forms or states as
closely as possible [108]. A major advantage of the MST approach
is that the algorithm may result in trees with star-like branches,
which allows for a correct classification of population systems that
have a strong mutational or recombinational rate, such as P.
aeruginosa, and where a large number of single locus variants (SLVs)
may evolve from one common type [7]. As mentioned above,
MSTs can be calculated from a true distance matrix. A distance
matrix based upon a data matrix (in the case of fingerprint type
data, derived after a global band matching), whether derived from
one or multiple data sources, can be used. In theory, every
distance coefficient applied on a data matrix produces a distance
matrix suitable for analysis with the MST method [108]. Recently
MST was used to determine the phylogenetic framework of Listeria
monocytogenes [110]. In this study MST was used, for the first time,
to link the Polyphasic Profiles (PPs) of 328 unrelated P. aeruginosa
strains in such a way that the sum of the distances (number of
differences between two distinct PPs) is minimized.
In our previous P. aeruginosa population structure study a
UPGMA dendrogram, based on the comparison of the composite
data set consisting of 4 markers in 73 strains, revealed 7 distinct
clonal complexes, arbitrarily labelled CC A to CC G [13]. In the
present MST, based on the composite similarity matrix derived
from the combination of 7 markers in 328 strains (Figure 7), we
identified 4 additional clonal complexes (CC H to CC K). The
former CC C was renamed ‘clone O12’ to avoid confusion with
the worldwide CF and aquatic clone C [3] and the former CC B
disappeared as its members no longer clustered into a distinct
clonal complex. We also observed several distinct isolates with a
unique PP, some of which diverged considerably from the rest of
Figure 5. Congruence between experiments, as calculated using the Pearson product-moment correlation coefficient.
doi:10.1371/journal.pone.0007740.g005
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Figure 6. UPGMA dendrograms, with assignment of allele codes, for the oprI (a), oprL (b), and oprD (c) alleles detected in 328 P.
aeruginosa strains.
doi:10.1371/journal.pone.0007740.g006
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the population (e.g. reference strains PA7 and UCBPP-PA14).
Strains isolated from inanimate environments, animals and
humans, separated by thousands of miles, often clustered into
the same clonal complex, confirming that, in general, there is no
clear correlation between the clonal complexes and geographical
origin or (disease) habitat. As in our previous study, there was
again strong evidence that the relation among the isolates was
distorted by recombination. We observed a network of relation-
ships between all analysed parameters (Figure 1, Figure 2, Figure 3,
Figure 4) and a relatively low congruence between experiments
(Figure 5). Evidence of recombination is additionally supported by
the mosaic structure of the oprD gene (http://www.pseudomonas.
com/related_links.jsp#alleles), which is the result of a history of
intra and possibly inter species recombinational exchanges of
DNA blocks [74]. We also observed several conserved clones,
characterized by an almost identical data set (Figure 1, Figure 2,
Figure 3, Figure 4) and represented by relatively large numbers of
isolates (circles) in the MST (Figure 7). The results of this
polyphasic characterization confirm the nonclonal epidemic
population structure of P. aeruginosa, i.e. a superficially clonal
structure with frequent recombinations, in which occasionally
highly successful epidemic clones arise.
A conventional UPGMA dendrogram based on the composite
similarity matrix is shown in Figure S2.
CF ‘‘transmissible’’ clones
According to this study, a typical CF strain shows the following
profile: non- or polyagglutinable (76.5%), oprD goup B (93.0%), oprL
group B (97.7%), exoS+ (97.7%) and fpvB+ (100%) (Table 3). Although
CF isolates exhibited a genetic diversity that was comparable to that
observed in other habitats, all of them, with the exception of Li004,
clustered in, or were located at the border of what appears to be a large
‘core lineage’ (Figure 7). This ‘core lineage’ seems to be predominant in
disease and environmental habitats across the world and is composed
of CCs A, D and J (Figure 7). Li004 was isolated from a CF patient in
Lisbon (Figure 3), but it remains unclear whether it is an ‘early’
Table 4. Analysis of the oprI, L, and D nucleotide sequence data in 328 P. aeruginosa strains.
Gene Size (bp) No. of alleles No. of variable sites % Variable sites Max. nucleotide distance between alleles (%)
oprI 249 6 7 2.8 1.5
oprL 504 33 27 5.4 4.0
oprD 1323 or 1329 67 274 20.7 9.5
doi:10.1371/journal.pone.0007740.t004
Table 5. Defective oprD mutations (DOMs) in 328 P. aeruginosa isolates.
DOM Strain Mutation
1 Be128 Large deletion starting from NT 874 and covering the termination codon
2 Is573 CRT base substitution at NT 1018 R premature termination
3 Aa245 CRT base substitution at NT 1243 R premature termination
4 Bu007 GRT base substitution at NT 511 R premature termination
5 C19 GRA base substitution at NT 413 R premature termination
6 Li010 GRA base substitution at NT 831 R premature termination
7 Aa249 TRC base substitution at NT 32 R leucine replaced by proline in signal peptide
8 Br670 TRC base substitution at NT 1076 R leucine replaced by proline in external loop 7
9 Br718 Duplication between GCGCGG repeats (NT 573-8 and 617-22) R frameshift R stop codon at NT 730-2
10 Pr317 1-base duplication at monotonic repeat CCCC (NT 346-9) R frameshift R stop codon at NT 352-4
11 Mi162 1-base deletion at monotonic repeat CCCC (NT 346-9) R frameshift R stop codon at NT 379-81
12 Bo548 1-base deletion at monotonic repeat GGGGG (NT 631-5) R frameshift R stop codon at NT 713-5
13 Br993/678 Large deletion covering initiation codon
14 PHLS08960 ART base substitution at NT 886 R premature termination
15 LUH7552 Duplication of GCC at NT 859-62 R frameshift R stop codon at NT 913-5
16 KAT3529 Deletion of A at NT 1082 R frameshift R stop codon at NT 1294-6
17 MC116 Deletion of AA at NT 820-1 R frameshift R stop codon at NT 1090-2
18 MC039 CRT base substitution at NT 883 R premature termination
19 MC325 Duplication of C at NT 540 R frameshift R stop codon at NT 580-2
20 1709-12 GRA base substitution at NT 195 R premature termination
21 PN1296 Deletion of G at NT 423 frameshift R stop codon at NT 713-5
NT, nucleotide.
doi:10.1371/journal.pone.0007740.t005
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sporadic strain or a ‘late’ persistent strain. All characteristics that were
associated with the CF niche (exoS, group B oprL, group B oprD, fpvA
type II and presence of fpvB) in this study were also prevalent in this
‘core lineage’. This supports the argument that not one parameter in
itself, but rather a multitude of linked characteristics are responsible for
the selection of particular strains in the CF niche.
Although CF strains isolated in different locations across the
world were shown to be genotypically non-identical and thus
Figure 7. Minimum spanning tree of the similarity matrix of the composite data set consisting of the FAFLP pattern, serotype, oprI,
oprL, and oprD gene sequences, pyoverdine receptor profile and prevalence of exoS/U for 328 P. aeruginosa strains. Each circle
corresponds to a polyphasic profile (PP). The circles are scaled with member count. Branch lengths are logarithmic. Coloured zones surround PPs that
belong to the same clonal complex. These complexes are also indicated with a capital letter. The lines between PPs indicate inferred phylogenetic
relationships and are represented as bold, plain, discontinuous and light discontinuous depending on the number of differences between profile
types. Discontinuous links are only indicative. Two bold black indent lines delimit the P. aeruginosa ‘‘core lineage’’; the MDR serotype O12 clone is
encircled by a red dotted line.
doi:10.1371/journal.pone.0007740.g007
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probably not directly related (Figure 1, Figure 2, Figure 3, Figure 4,
and Figure 7), they all clustered into the ‘core lineage’. It is thus
quite understandable that CF strains isolated in distant places
show some level of relatedness, which should however not be
confused with clonality. Lanotte et al. determined some genetic
features of 162 isolates from different ecological origins [111] and
found that 3 major genogroups of P. aeruginosa isolates were able to
colonize CF patients. Unfortunately, due to different choices of
typing techniques and strains between studies, we are not able to
match these genogroups to our clonal complexes.
Occasional transmission of CF strains in CF clinics and holiday
or rehabilitation camps has been reported [37,112,113]. Our
results indicate that a widespread or global transmission of
successful P. aeruginosa CF strains is unlikely to have occurred. Our
data suggest that strains belonging to the successful ‘core lineage’
are ubiquitous in the natural environment and are therefore more
likely to infect CF patients. In 1994, Ro¨mling et al. observed that
clone C, the major clone in the CF population in Germany, was
also overrepresented in soil and aquatic habitats, and suggested
that the isolation frequency in CF patients simply reflected the
distribution of clones in the environment [3].
MDR serotype O11 and O12 strains
All confirmed MDR O12 strains, showing resistance to one or
more representatives of at least 3 antibiotic classes (Figure 1, Figure 2,
Figure 3, Figure 4), clustered into a very conserved clone (Figure 7).
These strains typically exhibited the following profile: serotype O12
(100%), oprD goup A (100%), oprL group B (100%), oprI group B
(100%), exoS+ (100%), fpvB+ (100%) and tfpOb+ (100%) (Figure 1,
Figure 2, Figure 3, Figure 4, and Table 3). MDR serotype O11
strains, in contrast, clustered into CCs F, G, H and I (Figure 7) and
showed an overall higher genetic divergence (Figure 1, Figure 2,
Figure 3, Figure 4, and Table 3). Serotyping of 7089 P. aeruginosa
strains, isolated in 16 Belgian hospitals in the period from 1977 to
1986, revealed a steady increase of P. aeruginosaO12 isolates from 2%
in 1982 to 22% in 1986 [114]. The majority of these O12 isolates
showed the same distinctive pyocin and phage types, suggesting a
high degree of homogeneity within the O12 strains in Belgium. A
multicentre European study provided evidence for a commonO12 P.
aeruginosa strain in Europe [41]. In the present study, all MDR O12
strains, isolated between 1985 and 2006 in 9 countries, some of them
separated by thousands of miles, were shown to cluster into a very
conserved clone exhibiting virtually no divergence after more than 20
years of ‘evolution’ (Figure 1, Figure 2, Figure 3, Figure 4, and
Figure 7). This MDR O12 clone consists exclusively of clinical
isolates; absolutely no environmental, animal or CF isolates were part
of this clone (Figure 7). Furthermore, only recent strains, isolated post
1980, clustered into this clone (Figure 1, Figure 2, Figure 3, Figure 4,
and Table 3). These observations could be indicative of a recent,
rapid and widespread dissemination. Natural forces are likely to
sustain global dispersal of organisms as small and abundant as
bacteria [115], but the increased mobility of humans and the
simultaneous worldwide increase of high care facilities is likely to have
accelerated the dispersal of these MDR epidemic strains. One could
state that the MDR O12 clone is a genuine global epidemic clone.
Strains can acquire characteristics (e.g. antibiotic resistance determi-
nants), which are advantageous in a specific niche (e.g. an intensive
care unit) and this can lead to a rapid clonal expansion. The O12
clone was, to the best of our knowledge, never isolated from the
natural environment and it has been suggested that colonised or
infected patients might be the primary reservoirs of the prevalent O12
clone [54,116].
We feel that the emerging MDR O12 clone is an example of a
rapid and sustained adaptation of P. aeruginosa to a novel
environment. Man-made changes to the (hospital) environment,
like the introduction of antimicrobials, are affecting the P.
aeruginosa population structure.
Conclusion
This present study is to our knowledge the first report of an
MST analysis conducted on a polyphasic data set. The population
structure of P. aeruginosa was determined by means of a
combination of seven valuable experiments. Analysis and
clustering based on a single experiment broadly conserved the
clonal complexes and clones designated in the MST based on the
combined experiments (Figure 1, Figure 2, Figure 3, Figure 4).
The relationship between these groups of strains, however, varied
according to the considered experiment, which is visualized as a
mosaic pattern in Figure 1, Figure 2, Figure 3, Figure 4.
Therefore, we are convinced that the ultimate or ‘true’ population
structure is most faithfully approached combining as many
experiments as feasible, which are then again performed on as
many unrelated and diverse strains as feasible.
This polyphasic characterization of 328 diverse and unrelated P.
aeruginosa strains confirmed the nonclonal epidemic population
structure of P. aeruginosa. Our results also indicate that there are no
widespread CF epidemic clones. CF strains are part of a successful
and ubiquitous ‘core lineage’ that have infected CF patients from
the natural environment and spread through short to medium
range transmission between patients in CF clinics and holiday and
rehabilitation camps, possibly helped by breaches in basic
infection control measures. In contrast, we report the worldwide
spread and persistence of MDR clone O12. The excessive use of
antibiotics has caused a worldwide ‘unnatural’ selection for
multiply resistant or even panresistant P. aeruginosa strains.
We hope that the evolutionary framework presented in this study
will serve as the basis for more specific studies that will prove helpful
in designing public health policies (e.g. segregation of CF patients or
not). Additionally, the exchange of standardized data between
laboratories and the creation of international reference databases of
typed microorganisms should be encouraged. It will enable an
efficient monitoring of changes in microbial populations and
consequently allow more adequate infection control measures.
Knowing a species population structure and evolutionary paths is
the cornerstone of strategies aiming to control it. Specialised follow-
up papers, based on the evolutionary framework presented here and
dealing with some clinically relevant issues, are in preparation.
Materials and Methods
P. aeruginosa isolates
A total of 328 P. aeruginosa clinical and environmental isolates,
collected worldwide (69 localities, 30 countries and 5 continents)
were examined (Table 1).
Most of them were isolated in the late eighties and nineties, but
49 were isolated before 1980, including 14 P. aeruginosa strains
isolated at the ‘Institut Pasteur’ in Paris by Carle Gessard [1] and
his colleagues in the late 19th century. The studied collection
contained 185 human clinical isolates (including 43 CF, 33 burn,
32 wound, 18 urine, 15 sputum, 6 faeces and 5 blood isolates), 63
animal clinical isolates (39 dogs, 6 turtles, 4 horses, 3 parrots, 3
dolphins, 2 cats, 2 cows, 1 kangaroo, 1 goat, 1 rabbit and 1 seal)
and 55 environmental isolates (17 sea water, 16 river water, 6 lake
water, 5 turtle egg, 4 plant, 3 tap water, 2 swimming pool water
and 2 drink water isolates). Geographical origin, isolation site and
time and other relevant characteristics of all P. aeruginosa isolates
can be found in Figure 1, Figure 2, Figure 3, Figure 4.
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The P. aeruginosa strains were kindly provided by: Dr. A. T.
McManus, US Army Institute of Surgical Research, Texas, USA;
Dr. L. Me´nesi, General Hospital St. Istvan, Budapest, Hungary;
Dr. A. Vanderkelen, Dr. S. Jennes, G. Verbeken and D. Schoeters,
Queen Astrid Military Hospital, Neder-Over-Heembeek
(Brussels), Belgium; Dr. J. A. Clark, Queen Mary’s University
Hospital, London, England; Dr. A. F. Vloemans, Rode Kruis
Ziekenhuis, Beverwijk, The Netherlands; Dr. T. Taddonio,
University of Michigan, Michigan, USA; Dr. A. Radke, Klinik
fu¨r Verbrennungs- und Plastische Wiederherstellungschirurgie,
Aachen, Germany; Prof. R. Konigova, Charles University
Hospital, Prague, Czech Republic; Dr. R. G. Tompkins, Burns
Institute, Shriners Hospital for Children, Boston, USA; Prof. B.
Tu¨mmler, Medizinische Hochschule, Hannover, Germany; Dr.
M. Caneira, Hospital de Santa Maria, Lisboa, Portugal; Prof. A.
Boudabous, Science Faculty, Tunis, Tunisia; Dr. M. Mergeay,
Environmental Technology Expertise Centre, Mol, Belgium; Dr.
A. E. Lim Jr., St. Scholastica’s College of Health Sciences,
Tacloban City, Philippines; Prof. O. Hadjiiski, Scientific Institute
of Emergency Medicine Pirogov, Sofia, Bulgaria; Prof. K.
Taviloglu, University of Istanbul, Istanbul, Turkey; Dr. W. D.
H. Hendriks, Zuiderziekenhuis, Rotterdam, The Netherlands; Dr.
G. Wauters, University of Louvain, Brussels, Belgium; Dr. O.
Vandenberg, Universitair Ziekenhuis St.-Pierre, Brussels, Belgium;
Prof. M. Vaneechoutte, University Hospital Ghent, Gent,
Belgium; Prof. J. Van Eldere, Catholic University of Leuven,
Leuven, Belgium; Dr. U. Ro¨mling, Karolinska Institute, Stock-
holm, Sweden; Dr. L. Roddam and R. Bradbury, University of
Tasmania, Hobart, Australia; Dr. T. L. Pitt, Health Protection
Agency, London, UK; Dr. A. Leita˜o, Faculty of Veterinary
Medicine, Lisboa, Portugal; Dr. R. W. Brimicombe, Haga
Ziekenhuis, Den Haag, The Netherlands; Prof. N. J. Legakis
and Dr. P. T. Tassios, National and Kapodastrian University of
Athens, Athens, Greece; Prof. J.-M. Meyer, University Louis
Pasteur, Strasbourg, France and Dr. M. P. Crespo, Universidad
Santiago de Cali, Cali, Colombia; Dr. M. Merabishvili and Dr.
Nina Chanishvili, Eliava Institute, Tbilisi, Georgia; Dr. L.
Griffiths, Dr. K. Craven and J. Awong-Taylor, Armstrong Atlantic
State University, Savannah, US; Prof. M. de Chial, University of
Panama, Panama City, Panama; Dr. N. H. Khan, Dr. N. Kimata
and Prof. K. Kogure, University of Tokyo, Tokyo, Japan; Dr. D.
Armstrong, Monash Medical Center, Melbourne, Australia; A.
Catrijsse, Vlaams Instituut voor de Zee, Oostende, Belgium.
Strains LMG 2107, 5031, 10643, and 14083-5 were purchased
from the BCCMTM/LMG bacteria collection. The 20 ‘CPHL
(Central Public health Laboratory) strains’ were purchased from
the National Collection of Type Cultures in London (UK). Strain
PAO-1 was kindly provided by Dr. C. K. Stover (PathoGenesis
Corporation, Seattle, USA). Strain ATCC 27853 was purchased
from Gibson Laboratories (USA).
All isolates were grown overnight in Luria-Bertani broth
medium (Gibco-BRL-Life Technologies, Belgium) at 37uC on a
rotary shaker (150 rpm). The overnight cultures were mixed with
equal amounts of sterile 50% (vol/vol) glycerol (Sigma Aldrich,
Belgium) in PBS buffer (Sigma Aldrich, Belgium) and stored in
duplicate at 280uC.
FAFLP
FAFLP utilized an ABI 377 automated fluorescence sequencer
(Applied Biosystems, Belgium), and the AFLPTM Microbial
Fingerprinting Kit (Applied Biosystems) as detailed in the
manufacturer’s protocols. The enzymes used were T4 DNA
ligase, EcoRI, and Tru9I (all purchased from Roche Diagnostics,
Belgium). The primer pair used was EcoRI-0[FAM]/MseI-C.
GeneScan-500[ROX] internal standard (Applied Biosystems) was
co-electrophoresed with each sample in order to allow an accurate
calculation of fragment lengths and correction for variation rates
and gel distortions. Normalization and fragment sizing were
carried out using GeneScan software (Applied Biosystems,
Belgium). Band patterns were imported into the BioNumerics
v5.1 software (Applied Maths, Belgium) and normalised; param-
eters used: background subtraction (10% disc diameter), filtering
(arithmetic average), band search (minimum profiling 0.5%
relative to the maximum value). Cluster analysis was performed
by pairwise calculation of the Pearson correlation; the similarity
matrix was clustered using the UPGMA algorithm with optimi-
sation: 0%, position tolerance: 1%; uncertain bands were ignored.
Serotyping
Strains were grown overnight on Luria-Bertani agar medium
(Gibco-BRL-Life Technologies) at 37uC. Isolates were serotyped
by slide agglutination according to the International Antigenic
Typing Scheme (IATS) for P. aeruginosa [117], using a panel of 16
type O monovalent antisera (Bio-Rad, Belgium). Some strains had
already been serotyped by the strain providers (e.g. isolates LMG
14084 and CPHL 12447, which were shown to exhibit the
provisionary O17 and O18 serotypes).
PCR and sequencing
Strains were grown overnight in Luria-Bertani broth medium
(Gibco-BRL-Life Technologies) at 37uC on a rotary shaker
(150 rpm). DNA was extracted from the overnight cultures using
the High PureTM PCR Template Preparation Kit (Roche
Diagnostics) according to the manufacturer’s guidelines. The
complete oprI, oprL, and oprD genes and a fragment of the exoS,
exoU, fpvA, fpvB and tfpO genes were amplified by PCR, using the
primers described in Table 6. PCR was performed in 200-ml
microcentrifuge tubes. The PCR mixture (50 ml final volume)
contained the following: 25.5 ml sterile distilled water, 5 ml
106PCR buffer (500 mmol/l KCl and 100 mmol/l Tris-HCl:
pH 8.3), 4 ml of a deoxynucleotide mixture (dGTP, dTTP, dATP,
and dCTP; 2 mmol/l each), 5 ml MgCl2 (2.5 mmol/l), 5 ml of a
primer mixture (10 mmol/l each), 5 ml template DNA, and 0.5 ml
AmpliTaq DNA polymerase (5 U/ml). All PCR-reagents and
primers were ordered from PE-Applied Biosystems. The amplifi-
cation was performed in a GeneAmpH 9700 thermocycler
(Applied Biosystems). The amplification program was set at 50
cycles of denaturation at 94uC for 30 s, annealing at a temperature
in accordance to the primers (Table 6), for 30 s, and elongation at
72uC for 1 min. In a few strains the amplification of the fpvA gene
required degenerate primers. The reaction mixture was put on an
agarose gel of 1.5 % (wt/vol) for electrophoresis and visualization
of the PCR-product after staining with ethidium bromide on a
transilluminator. Prior to the sequencing of the oprD, oprL and oprI
genes, the respective PCR-products were purified, using centri-
conH 100 micro-concentrators (Millipore, Brussels, Belgium)
according to the manufacturer’s instructions. Five ml of the
purified PCR fragment was used as a template in the sequencing
reaction. PCR primers were used for sequencing. Sequencing of
the coding and anti-coding strand of the oprD PCR products
necessitated two additional internal primers (Table 6). DNA
sequencing utilized an ABI 377 automated fluorescence sequencer
(Applied Biosystems), and the ABI PrismH BigDyeTM Terminator
cycle sequencing kit (Applied Biosystems) as detailed in the
manufacturer’s protocols. The oprD gene of isolate Be128 was
sequenced directly from genomic DNA. Some genes were
sequenced in the VIB Genetic Service Facility (Belgium) using a
capillary Applied Biosystems 3730 DNA Analyzer. PCR and
P. aeruginosa Population
PLoS ONE | www.plosone.org 16 November 2009 | Volume 4 | Issue 11 | e7740
sequencing were performed in duplicate in order to be able to
detect eventual PCR mistakes.
Using the BioNumerics v5.1 software, sequences were grouped
via a pairwise clustering (pairwise alignment parameters: open gap
penalty: 100%, unit gap penalty: 0%, min. match sequence: 2,
max nu of gaps: 9, fast algorithm). The obtained UPGMA tree was
used to seed a multiple alignment (multiple alignment parameters:
open gap penalty: 100%, unit gap penalty: 0%, min. match
sequence: 2, max nu of gaps: 98). Finally, multiple aligned
sequences were clustered using the same parameters as used in the
initial pairwise clustering, resulting in the final UPGMA tree.
Conbined data analysis
A data set consisting of the serotype, FAFLP pattern, oprI, oprL,
and oprD gene sequences, pyoverdine receptor profile (fpvA and
fpvB) and prevalence of the genes exoS and exoU of 328 P. aeruginosa
isolates was analyzed using the biological data analysis software
BioNumerics v5.1. The settings used for the comparison of the
FAFLP fingerprints and the gene sequences are described in the
respective paragraphs. Serotype, pyoverdine receptor profile and
presence of exoS/U were compared using the Pearson correlation.
These individual comparisons resulted in individual similarity
matrices, which were averaged into the similarity matrix of the
composite data set. No correction for internal weights was
applied. Each isolate was thus assigned a ‘polyphasic profile’ (PP)
contributing to the composite similarity matrix. Grouping of the
averaged composite similarity matrix was achieved by MST
analysis using BioNumerics v5.1 software. The MST coefficient
was taken from the composite similarity matrix. The Degeneracy
of the MST was reduced through the use of a priority rule by
which types that had a maximum number of entries were linked
first, confirming a biological meaning that these clones are most
likely older. For visual purposes, isolates were further grouped
into clonal complexes. For the creation of the clonal complexes,
the similarity bin size (1 change) was set to 2.5%; the maximal
neighbour distance between two complexes was 5 changes
(12.5%) and the minimum size of a complex was 5 types.
Originally a clonal complex was defined as a cluster of STs in a
burstdiagram in which all STs are linked as SLVs to at least one
other ST. In our case a clonal complex is a cluster of PPs, after
MST analysis, in which all PPs with less than 5 changes ( = less
than 12.5% distance in the similarity matrix) are linked.
Congruence between experiments was calculated using the
Pearson product-moment correlation coefficient between the
respective similarity matrices.
Antimicrobial susceptibility tests
Strains were grown 18–24 h at 37uC on Columbia agar
containing 5% horse blood (bioMe´rieux). Suspensions of these
cultures were made in 0.45% saline, adjusted to the turbidity of a
Table 6. Primers for PCR and sequencing.
Target Primer Sequence (59 to 39) Tm (uC) Size (bp) Reference
oprI PS1 ATGAACAACGTTCTGAAATTCTCTGCT 57 248 [70]
PS2 CTTGCGGCTGGCTTTTTCCAG
oprL PAL1 ATGGAAATGCTGAAATTCGGC 57 504 [70]
PAL2 CTTCTTCAGCTCGACGCGACG
oprD DF1 ATGAAAGTGATGAAGTGGAGC 49 1323-9 [13]
DR1 CAGGATCGACAGCGGATAGT
oprD (for sequencing) DF2 AACCTCAGCGCCTCCCT 49 NA [13]
DR2 AGGGAGGCGCTGAGGTT
fpvA I fpvAIf CGAACCCGACGAAGGCCAGA 52 324 [81]
fpvAIr GTAGCTGGTGTAGAGGCTCAA
fpvA IIa fpvAIIaf TACCTCGACGGCCTGCACAT 52 908 [81]
fpvAIIar GAAGGTGAATGGCTTGCCGT
fpvA IIb fpvAIIbf GAACAGGGCACCTACCTGTA 52 863 [81]
fpvAIIbr GATGCCGTTGCTGAACTCGTA
fpvA III fpvAIIIf ACTGGGACAAGATCCAAGAGA 52 505 [81]
fpvAIIIr CTGGTAGGACGAAATGCGA
fpvB fpvBf GCATGAAGCTCGACCAGGA 52 562 [81]
fpvBr TTGCCCTCGTTGGCCTTG
exoS exoSF TCAGGTACCCGGCATTCACTACGCGG 55 572 [98]
exoSR TCACTGCAGGTTCGTGACGTCTTTCTTTTA
exoU exoUF AGCGTTAGTGACGTGCG 55 1572 [98]
exoUR GCGCATGGCATCGAGTAACTG
tfpOa tfpOup CGTACTATTCTATTATTGCTGA 55 849 [86]
tfpOdown CAAAGGATGGGCTACGAA
tfpOb tfpO2up CTGATGCTGTTTTCCTTC 55 551 [86]
tfpO2down GCATCTCGCCACAACACG
Tm: annealing temperature.
doi:10.1371/journal.pone.0007740.t006
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0.6 McFarland standard, and used to load the test cards for
VITEK 2 (bioMe´rieux), which was used in accordance with the
manufacturer’s directions. The following antibiotics were tested
using the AST-N020 antimicrobial susceptibility cards: AMP,
ampicilin; AMC, amoxicillin + clavulanic acid; PIP, piperacillin;
TZP, piperacillin + tazobactam; CEF, cephalothin; CXM,
cefuroxime; CTX, cefotaxime; CAZ, ceftazidime; CPD, cefpo-
doxime; FOX, cefoxitin; FEP, cefepime; MEM, meropenem;
GEN, gentamicin; TOB, tobramycin; AMK, amikacin; NOR,
norfloxacin; OFX, ofloxacin; CIP, ciprofloxacin; NIT, nitrofuran-
toin; SXT, trimethoprim + sulfamethoxazole. Antibiotic resistance
phenotypes, represented by the minimum inhibitory concentra-
tions (MICs) for the above-mentioned antibiotics, were determined
using VITEK 2 Advanced Expert System (AES) [118]. P. aeruginosa
ATCC 27853 was used as control strain. For some isolates the
MIC was determined by the broth microdilution method [119].
Nucleotide sequences
The nucleotide sequences generated in this study have been
deposited in the Pseudomonas aeruginosa Genome database (http://
www.pseudomonas.com/related_links.jsp#alleles).
Strain collection
All studied P. aeruginosa strains were deposited in the Belgian
Coordinated Collections of Microorganisms (BCCM) of the
Laboratorium voor Microbiologie (LMG) of the Ghent University.
Strains were assigned a BCCM/LMG number (LMG 24881 -
25202). Strains that were obtained from a culture collection
(BCCM/LMG or ATCC) maintained their original reference
number.
Strains can be obtained from the LMG bacteria collection for
research use only and with the consent of the strain donors.
Supporting Information
Figure S1 UPGMA dendrogram of the FAFLP patterns of the
328 studied P. aeruginosa strains.
Found at: doi:10.1371/journal.pone.0007740.s001 (0.42 MB
PDF)
Figure S2 UPGMA dendrogram of the similarity matrix of the
composite data set consisting of the serotype, FAFLP pattern, oprI,
L, and D gene sequences, pyoverdine receptor profile and
prevalence of exoS/U genes for the 328 studied P. aeruginosa strains.
Found at: doi:10.1371/journal.pone.0007740.s002 (0.02 MB
PDF)
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